Loading...
Back to narrative

Update shared on06 Oct 2025

Fair value Increased 5.05%
AnalystConsensusTarget's Fair Value
JP¥4,161.67
2.4% overvalued intrinsic discount
06 Oct
JP¥4,263.00
Loading
1Y
61.2%
7D
4.3%

Analysts have raised their price target for Japan Post Insurance from ¥3,961.67 to ¥4,161.67, citing modest improvements in revenue growth expectations and overall fair value estimates.

What's in the News

  • An upcoming board meeting is scheduled for July 29, 2025 to discuss agreements for a major investment in a reinsurance co-investment vehicle. (Key Developments)
  • Japan Post Insurance plans to invest $2 billion, approximately JPY 300 billion, into a new reinsurance entity as part of its ongoing growth strategy. (Key Developments)
  • The new reinsurance vehicle aims to capture large reinsurance transaction opportunities and raise capital from investors. (Key Developments)

Valuation Changes

  • The Fair Value Estimate has increased from ¥3,961.67 to ¥4,161.67, reflecting a modest rise in analyst expectations.
  • The Discount Rate remains nearly unchanged at 4.72%.
  • The Revenue Growth projection has increased slightly, from 23.52% to 23.86%.
  • The Net Profit Margin has remained stable at 2.38%.
  • The Future P/E Ratio has increased from 10.22x to 10.66x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.